We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

New findings show Epstein-Barr virus reactivation in blood  can precede MS relapse by up to 3 months. More...
17 Sep 2026
Image: CN-3000 and CN-6000 automated hemostasis analyzers for mid- and high‑volume laboratories are now available for patient testing in the United States. (Photo courtesy of Siemens Healthineers)

New Automated Hemostasis Systems Become Available Across US Laboratories

Siemens Healthineers’ CN-3000 and CN-6000 automated hemostasis analyzers are now available for patient testing in the United States. More...
17 Sep 2026
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Guidelines recommend targeted CLIA updates to ensure safe, validated AI use in clinical labs, with risk-based oversight. More...
17 Sep 2026
image Credit: iStock

Tumor Budding Grading May Predict Chemotherapy Benefit in Resected Lung Squamous Cancer

A tumor budding-based grading system identifies high-risk patients after lung squamous cell carcinoma surgery. More...
17 Sep 2026
Image: A very high magnification micrograph of Gaucher disease, the most common lysosomal disorder (Image Credit: Nephron/Wikimedia Commons, CC BY-SA 3.0)

Researchers Classify 108 Lysosomal Disorders in Updated Diagnostic Framework

A new classification framework expands lysosomal disorders to 108, enhancing diagnosis and informing screening and trials. More...
17 Sep 2026
Image: Acute myeloid leukemia is an aggressive blood cancer in which relapse remains a major challenge, making MRD detection critical for risk assessment and treatment planning (Image Credit: Shutterstock)

Variation in AML Residual Disease Testing Prompts Push for Standardization

Findings show measurable residual disease flow cytometry results for acute myeloid leukemia vary widely. More...
17 Sep 2026
Image Credit: Adobe Stock

CAP Updates Cancer Protocols to Refine Breast Cancer Biomarker Reporting and GIST Molecular Testing

CAP has introduced revisions to 14 Cancer Protocols to align cancer reporting with evolving WHO classifications. More...
17 Sep 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Immunofluorescence Analyzer
IFA System
Electrolyte Analyzer
BKE-B
Copyright © 2000-2026 Globetech Media. All rights reserved.